Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Melnikov

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab]O V Boyko, I I Choroshilova, S V Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 25, 2022
[The role of macrophages in the development of neuroinflammation in multiple sclerosis]M V Melnikov, A A Sviridova, V S Rogovskii, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[The role of dopamine receptors in the modulation of mononuclear phagocytes in multiple sclerosis]A V Lopatina, A A Sviridova, O O Belousova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[The influence of catecholamines on Th17-cells in multiple sclerosis]M V Melnikov, O O Belousova, R R Zhetishev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 10, 2023
[The influence of fluoxetine on neuroimmune interaction in multiple sclerosis]M V Melnikov, A V Lopatina, A A Sviridova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2019
[Serotonergic system as a therapeutic target in multiple sclerosis]A A Sviridova, M V Melnikov, O O Belousova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 24, 2018
[Gut human microbiota and multiple sclerosis]M Kh Kozhieva, M V Melnikov, V S Rogovsky, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 27, 2020
[The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro]L V Krivenko, A A Sviridova, M V Melnikov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis]M V Melnikov, A A Sviridova, T V Solodova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Norepinephrine and intestinal microbiome in the early stages of demyelination: clinical-immunological parallels]A A Sviridova, A R Kabaeva, V S Rogovskii, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab]O V Boyko, I I Choroshilova, S V Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 25, 2022
[The role of macrophages in the development of neuroinflammation in multiple sclerosis]M V Melnikov, A A Sviridova, V S Rogovskii, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 23, 2024
[The role of dopamine receptors in the modulation of mononuclear phagocytes in multiple sclerosis]A V Lopatina, A A Sviridova, O O Belousova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017
[The influence of catecholamines on Th17-cells in multiple sclerosis]M V Melnikov, O O Belousova, R R Zhetishev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 10, 2023
[The influence of fluoxetine on neuroimmune interaction in multiple sclerosis]M V Melnikov, A V Lopatina, A A Sviridova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2019
[Serotonergic system as a therapeutic target in multiple sclerosis]A A Sviridova, M V Melnikov, O O Belousova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 24, 2018
[Gut human microbiota and multiple sclerosis]M Kh Kozhieva, M V Melnikov, V S Rogovsky, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 27, 2020
[The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro]L V Krivenko, A A Sviridova, M V Melnikov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis]M V Melnikov, A A Sviridova, T V Solodova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Norepinephrine and intestinal microbiome in the early stages of demyelination: clinical-immunological parallels]A A Sviridova, A R Kabaeva, V S Rogovskii, et al.
Pageof 3